Health · Medical Research · 36 mins ago
Urgo says it has created living artificial skin for grafts
Urgo says it has created living artificial skin in a laboratory that can be grafted onto patients.
The French company developed it with the Centre for Stem Cell Studies, the French Blood Establishment and Dassault Systèmes.
The skin is intended for people with severe burns, who may lose large areas of their skin.
Current treatment takes skin from parts of the patient's body that remain unburned, which can mean several operations and more wounds.
Urgo says the new skin could be frozen, transported to a hospital and thawed for surgery.
The project is moving from research to clinical studies, with the company aiming to treat its first patient from 2030.
Urgo hopes to sell the treatment by 2040; the project is expected to cost €100 million, including €20 million in state support.
Urgo president Guirec Le Lous says the company has created living artificial skin in a laboratory that is ready for grafting onto patients.
The innovation is intended for people with severe burns and could replace autografts, which can require several operations.
Urgo developed the skin through a partnership with the Centre for the Study of Stem Cells, the French Blood Establishment and Dassault Systèmes.
The project is entering clinical study after its research phase, with the first patient planned from 2030 and commercialisation hoped for by 2040.
The project costs €100 million, including €20 million in state support.
- Who
- Urgo, whose president is Guirec Le Lous, announced the development.
- What
- The company says it has created living artificial skin in a laboratory for grafting onto patients.
- When
- Le Lous announced it on 20 November 2026.
- Where
- The announcement was made on France Inter. The skin was created in a laboratory; its location is not stated.
- Why
- It is intended to replace autografts for patients with severe burns, which can require several operations.
This story does not have two clearly opposing sides.
Urgo president Guirec Le Lous announced the laboratory-created skin on France Inter.
The project is moving into clinical study.
Urgo plans for the first patient and a scale-up to industrial production.
Le Lous hopes the product will be commercialised.
- Project cost
- €100 million
- State support
- €20 million
- Partnership
- Centre for the Study of Stem Cells, French Blood Establishment and Dassault Systèmes
- Storage temperature
- -150 degrees
- Intended patients
- People with severe burns, who may lose up to 80% of their skin surface
2 sources
What people are saying
une vraie peau artificielle vivante prête à être greffée sur des patients
une première mondiale
L'objectif, c'est de remplacer l'autogreffe qui, aujourd'hui, nécessite plusieurs opérations